Baxter International Inc. (NYSE:BAX) went up by 0.72% from its latest closing price compared to the recent 1-year high of $95.19. "Our multiyear transformation has positioned us with the strength and adaptability to address today’s unique challenges while continuing to identify opportunities to drive additional value for patients, clinicians, communities and shareholders.". Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter’s GBUs and geographic segments. More details on the ACT program are now posted on the Baxter website. {�cN� November 3, 2020 For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. Generally, the company reports earnings better than estimates. �H�����|!b�>޹ �IFW^���M�V���0���s !ӷc�خ�,@GK���y�a�����6�չC9sݥ��\jFiX��v����[{��?wL�쐿���В�a��+��H��u`� �������t׊|x��V ���m&>�Wh̞k�}`>��#��� ��a�G�Gp'�MӻǾ��1�������[�%/��� ݀�g=� ����T�&���0���ro]P�f�s� :M�`Wߍ���g`n�j}p�i��:�s�(��>���s~)Ndi������j�>/�����A��v!z!BD��}�� ;Ҕ�ϖ�P�Wl]�5�O��}X]{D�z�i����4��y�̫������е7!˽4�i{?���Q���J���OkI`o��We��q����!��KA!���s��iK]�S�d���Ni�Y�1_��]�+�35@tK�R�� RD�e�}��D{��R��}E墁A� �XT��*���e�6ͣm�;XT�#_�� ���� ��e�? Baxter International Inc. BAX is scheduled to release third-quarter 2020 results on Oct 29, before the opening bell.In the last reported quarter, the company delivered negative earnings surprise of 9.9%. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Baxter International Inc. (NYSE:BAX) Q3 2019 Earnings Conference Call. Patients’ journeys inspire our work and drive our commitment. Since then, the stock has moved both ways with losses outperforming gains. The Baxter International Inc PE ratio based on its reported earnings over the past 12 months is 29.54.The shares are currently trading at $80.04.. �2��{X�fN� Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter’s GBUs and geographic segments. Announces Earnings Release Date, Conference Call and Webcast for Fourth Quarter 2019 Results. As part of these efforts, the Baxter International Foundation has committed to a $2 million grant to the American Diabetes Association® focused on addressing diabetes education and care disparities affecting Black Americans. Latest Developments More. When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health. Adjusted earnings per diluted share increased 12% in the third quarter. We are a community of diverse professionals working together to drive better healthcare options. We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do. 4 0 obj • Baxter expects full-year U.S. GAAP EPS of $2.41 to $2.44; adjusted EPS of $3.02 to $3.05 DEERFIELD, Ill., OCT. 29, 2020 – Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported earnings for the third quarter of 2020 and updated its outlook for full-year 2020. October 24, 2019, 08:30 AM ET. Press Release • November 23, 2020 Baxter Announces U.S. FDA 510 (k) Clearance of Homechoice Claria with Sharesource Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients. Baxter International Inc. BAX is scheduled to release second-quarter 2020 results on Jul 30, before the opening bell.In the last reported quarter, the company delivered earnings surprise of 12.3%. ESG & Corporate Responsibility. From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital. 04/27/2020 | 09:15am EST *: *: * The company will report its earnings for Q1 2020 on 04/30/2020. For the quarter and year-to-date periods ended September 30, 2020 and projected full-year 2020, operational sales growth excludes the impact of foreign exchange and the company's recent acquisition of Seprafilm. �ZY�-�!2=p�%�� Management believes that non-GAAP financial measures, when used in conjunction with the results presented in accordance with U.S. GAAP and the reconciliations to corresponding U.S. GAAP financial measures, may enhance an investor’s overall understanding of the company's past financial performance and prospects for the future. Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. The non-GAAP financial measures include adjusted gross margin, adjusted selling, general and administrative expense, adjusted research and development expense, adjusted other operating income, net, adjusted operating income, adjusted operating margin, adjusted income before income taxes, adjusted income tax expense, adjusted net income, adjusted net income attributable to Baxter stockholders, and adjusted diluted earnings per share, all of which exclude special items, sales growth on a constant currency and operational basis, and free cash flow. Special items are excluded because they are highly variable or unusual, and of a size that may substantially affect the company's reported operations for a period. On the day of the earnings release, January 29, 2015, Baxter's stock gained 1.74% to end the session at $71.38. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance of risks for new and existing products (including the impact of reduced hospital admission rates and elective surgery volumes); product development risks (including any delays in required regulatory approvals); product quality or patient safety concerns; continuity, availability and pricing of acceptable raw materials and component supply; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of a natural disaster, public health crises and epidemics/pandemics, regulatory actions or otherwise); the impact of global economic conditions (including potential trade wars) and continuing public health crises and epidemics, such as the novel strain of coronavirus (COVID-19), including related resurgences, on us and our customers and suppliers, including foreign governments in countries in which we operate; breaches or failures of the company’s information technology systems or products, including by cyberattack, unauthorized access or theft (as a result of increased remote working arrangements or otherwise); the adequacy of the company's cash flows from operations (which may be negatively impacted by collectability concerns as a result of the COVID-19 pandemic or otherwise) and other sources of liquidity to meet its ongoing cash obligations and fund its investment program; loss of key employees or inability to identify and recruit new employees; future actions of regulatory bodies and other governmental authorities, including the FDA, the Department of Justice, the SEC, the New York Attorney General and foreign regulatory agencies, including the continued delay in lifting the warning letter at our Ahmedabad facility or proceedings related to the investigation related to foreign exchange gains and losses; the outcome of pending or future litigation, including the opioid litigation and litigation related to our internal investigation of foreign exchange gains and losses; the impacts of the material weakness identified as a result of the internal investigation and our remediation efforts, including the risk that we may experience additional material weaknesses or other deficiencies; proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end-stage renal disease market and demand for our peritoneal dialysis products, necessitating significant multi-year capital expenditures, which are difficult to estimate in advance; failures with respect to compliance programs; accurate identification of and execution on business development and R&D opportunities and realization of anticipated benefits (including the acquisitions of Cheetah Medical and Seprafilm Adhesion Barrier); future actions of third parties, including payers; U.S. healthcare reform and other global austerity measures; pricing, reimbursement, taxation and rebate policies of government agencies and private payers; the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies; fluctuations in foreign exchange and interest rates; the ability to enforce owned or in-licensed patents or the prevention or restriction of the manufacture, sale or use of products or technology affected by patents of third parties; global, trade and tax policies; any change in laws concerning the taxation of income (including current or future tax reform), including income earned outside the United States and potential taxes associated with the Base Erosion and Anti-Abuse Tax; actions taken by tax authorities in connection with ongoing tax audits; and other risks identified in Baxter's most recent filings on Forms 10-K and 10-Q and other SEC filings, all of which are available on Baxter's website. 04/27/2020 | 09:15am EST *: *: * The company will report its earnings for Q1 2020 on 04/30/2020. ��F*�N�Mz�Y��t�+r�ӽ �x�w���L{��]�3V���#�����T%��L����B[.�\��d�H�9�m ESG & Corporate Responsibility. On an adjusted basis, net income attributable to Baxter totaled $431 million in the third quarter, or $0.83 per diluted share. Baxter International is reporting earnings from Q3 on October 29. Earnings for Baxter International are expected to grow by 13.16% in the coming year, from $3.04 to $3.44 per share. Generally, the company reports earnings in line with the consensus. International sales of $1.7 billion grew 6% on a reported basis, 5% on a constant currency basis and 4% on an operational basis. Baxter expects GAAP earnings from continuing operations of $0.75 to $0.78 per share and adjusted earnings from continuing operations, before special items, of $0.82 to $0.84 per diluted share. Fourth-Quarter and Full-Year 2019 Earnings Announcement Baxter is proceeding diligently to complete its internal investigation related to certain intra-company transactions undertaken for the purpose of generating non-operating foreign exchange gains or avoiding losses, as first disclosed in its Current Report on Form 8-K on October 24, 2019. Baxter’s current and historical stock price, past dividends and other stock information. Company Participants Notably, Baxter mainly got a “hold” rating even after the company reported better-than-expected results in 1Q16 and raised its earnings guidance for fiscal 2016. Baxter Reports Third-Quarter 2020 Results, Supported a new investigator-initiated study, Announced U.S. Food and Drug Administration (FDA), Received U.S. FDA Emergency Use Authorizations (EUAs) for Baxter's, Announced a distribution agreement with bioMérieux, a global leader in in vitro diagnostics, for the. ... As you saw in today's press release, Baxter reported a year-over-year decline in both net sales and earnings … Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. Baxter Reports Third-Quarter 2020 Results. Joe Almeida shares his outlook on a range of topics. 2 0 obj Advancing American Kidney Health Initiative Finalized. Currently, the Zacks Consensus Estimate for … We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges. $342 (3%) earnings per share: basic: $0.65. Please see www.baxter.com for more information regarding this and future investor events and webcasts. Baxter Reports Third-Quarter 2020 Results Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis 1 Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12% Price to Earnings Ratio vs. the Market The P/E ratio of Baxter International is 45.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.74. J҇,���7m��^|��Eu�Y"��>��nr]J�"�6��sT%H8W[�j�g�h�(ks�5fQMK@�����!�B Future events or new information may result in different actual results. Press Release reported on 10/29/20 that Baxter Announces Proposed $650 Million Senior Notes Offering. FDA Says Baxter Healthcare Recalls Baxter Sigma Spectrum Infusion Pumps With Master Drug Library (Versions 6 And 8) Get the latest Baxter earnings report, revenues as well as upcoming BAX earnings dates, historical financial reports, news, analysis & more. 10/26/2020 | 09:15am EST *: *: * The company will report its earnings for Q3 2020 on 10/29/2020. FOR IMMEDIATE RELEASE Media Contact Steve Brett, (224) 948-5353 media@baxter.com Investor Contact Clare Trachtman, (224) 948-3020 BAXTER REPORTS SECOND-QUARTER 2020 RESULTS • Second-quarter revenue of $2.7 billion decreased 4% on a reported basis, 1% on a constant currency basis and 12% on an operational basis BAXTER REPORTS THIRD-QUARTER 2020 RESULTS •Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis1 •Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12% All rights reserved. Sales in the quarter, most notably in the Medication Delivery and Pharmaceuticals businesses, continue to be impacted by lower rates of emergency room utilization and hospitalizations in the wake of the pandemic. Baxter International ... of the non-GAAP financial measures being discussed today to the comparable GAAP financial measures is included in our earnings release issued … When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one. Last month the Centers for Medicare and Medicaid Services (CMS) announced the finalization of the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) payment model, a core component of the Advancing American Kidney Health Initiative (AAKHI). Baxter International Inc. BAX is scheduled to release second-quarter 2020 results on Jul 30, before the opening bell. Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. Baxter International Inc. : quaterly earnings release. Enriching the communities where we live and work. 1 See tables to the press release for reconciliations of non-GAAP measures used in this press release to the corresponding U.S. GAAP measures. Baxter International Inc has confirmed Earnings date and time. A webcast of Baxter's third-quarter 2020 conference call for investors can be accessed live from a link on the company's website at www.baxter.com beginning at 7:30 a.m. CDT on October 29, 2020. Resources & FAQs. Baxter International (BAX) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2019. Baxter International Inc. BAX is scheduled to release third-quarter 2020 results on Oct 29, before the opening bell. -�SĆqXFS���x��:z\~��]W����{� ��zY7\���E����X����L�c�jB �TژiF�,�]v�E�p��Ƕ�K Committed to helping you meet the evolving challenges and opportunities in patient care. endobj Get the latest Baxter earnings report, revenues as well as upcoming BAX earnings dates, historical financial reports, news, analysis & more. Baxter International Inc. : quaterly earnings release. This press release and the accompanying tables contain financial measures that are not calculated in accordance with U.S. GAAP. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook. net income attributable to baxter stockholders: $332. Analysts on Wall Street expect Baxter International will release earnings per share of $0.728. Baxter International ... of the non-GAAP financial measures being discussed today to the comparable GAAP financial measures is included in our earnings release issued … �\6$�*$���)IC����D��;�Qѡ��q������tHP����#�E�8�?�$S�����f� �`1c�A���ٮ0U3tO������� The first five lines of this table give us readings about the state of Baxter's debt. �N�Y��ӝ�[t*�_O�t����ь���f��n#"D�D��@Y�bC+g�*?�MC�v������!�1xs&�N�L����و %���� $0.67 (3%) diluted: $0.64. Worldwide sales in the third quarter totaled $2.97 billion, an increase of 4% on both a reported and constant currency basis, and 3% on an operational basis compared to the prior-year period. Baxter expects full-year U.S. GAAP EPS of $2.41 to $2.44; adjusted EPS of $3.02 to $3.05; Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported earnings for the third quarter of 2020 and updated its outlook for full-year 2020. Q3 Estimates. Baker Hughes Announces Date for Fourth Quarter and Full-Year 2020 Earnings Release and Webcast. Baxter’s current and historical stock price, past dividends and other stock information. Currently, the Zacks Consensus Estimate for first-quarter revenues is pegged at $2.86 billion, suggesting growth of 0.7% from the year-ago reported figure. '��aD��'�fD`(�.�x�w^�EE�!%sE@XO��mK8��G6�xf���]�=�gpFd���?�>��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d�. Net sales growth rates are also presented on an operational basis. In the last reported quarter, the company delivered a positive earnings surprise of 10.2%. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws. We’re engaging with industry thought leaders to explore how science and innovation advance healthcare. Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. Press Release • November 12, 2020 Baxter Canada Announces First Regulatory Approval of New Novum IQ Infusion Platform. endobj Knowing PMAEA for BAX three weeks before Earnings Announcement can provide unique advantages in trading Earnings. Baxter, Clinimix, Clinimix E, Regiocit, Seprafilm and Theranova are registered trademarks of Baxter International Inc. Other trademarks appearing here are the property of their respective owners. The report will be for the fiscal Quarter ending Dec 2020. Please see the schedules accompanying this press release for a reconciliation between the projected 2018 adjusted earnings per diluted share and projected GAAP earnings per diluted share. �(i�*���о�9�t����7���"���kBP�i��È�OɆ� MO ����sY�m��xF�e�tk���}f�6�=�aj�d�g���� ȧ�)�dG�\�Z�>t[]d�&.F�G���� ::�t��F0L��d�>u!JI�=�}� �[Χ7�}�� ���P!j���1ID4��"�����%��h�����S��GT5��ض /"��B��8W�F�f3�W�����2[�>�49�����"_G�. }����e7�\М���λ�9E˻��uZLBQE���O ��� �B�|��8:'�.�������հ! Press Release • September 18, 2019 BAXTER CANADA’S ‘WELCOME HOME’ NATIONAL GIVING PROGRAM COMMITS MORE THAN $150,000 IN ANNUAL DONATIONS AND HELPS OVER 2,000 PATIENTS ACROSS CANADA. Press Release • June 28, 2018 Baxter Releases 2017 Corporate Responsibility Report and Reinforces its Commitment to Enriching Communities Around the World. Fourth-quarter sales of $3.0 billion increased 7% on a reported basis and 9% on an operational basis 1; Fourth-quarter GAAP earnings per share (EPS) were a … Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. Baxter International Inc. (BAX Quick Quote BAX - Free Report) reported second-quarter 2020 adjusted earnings of 64 cents per share, which missed the Zacks Consensus Estimate of … From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind. This information should be considered in addition to, and not as substitutes for, information prepared in accordance with U.S. GAAP. Q2 Estimates. These results include special items totaling $67 million after-tax, primarily related to business optimization and intangible amortization. The company now expects adjusted earnings from continuing operations, before special items, of $3.27 to $3.35 per diluted share. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2020. Baxter continues to be recognized for its commitment to corporate responsibility and workplace excellence. On the bottom line, adjusted earnings per share were $0.83, up … These results helped offset a low single digit decline in Medication Delivery on a reported and constant currency basis. The company was most recently: For full-year 2020, Baxter expects sales growth compared to the prior-year period to be up low single digits on a reported, constant currency and operational basis. <> Growth across all three of Baxter's geographic segments and five of six global business units (GBUs) contributed to positive performance for the quarter at both reported and constant currency rates. Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. x��\�nG}7�� �5}�ˮ!�$ˎ�x�H26�x(j$�.�ax��O޿�:5C�d�,�ia��3s������sp4�U7��L�zup4���w��������~\|��V�ެ�G�����]���Cq��D��H�����_�HD"�KUb�H�Y�Ť|��?���J�� Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. 1 0 obj �����G:���H$Y�yru>I� 2�� ����m�`7������n]�_%I��Ğ��N:��>�l �7A��� \�U��X ��,�������;i��U�pXQNĴ��SQ�Ē�V�t&��], J�l ��+�g��\"�3Ѥ�L��H U��;#��F�I�!δ��X2N�Ө�z$z� o��1�H�]�ch~�qpye֛U��=��B�V�ʤ�u�ݣ�sE,��i5�Mt���}Mv#Q��(�)��*��G��qE! <>/Metadata 268 0 R/ViewerPreferences 269 0 R>> While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs. The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) for BAX three weeks prior to earnings date. Generally, the company reports earnings in line with the consensus. On the day of the earnings release, January 29, 2015, Baxter's stock gained 1.74% to end the session at $71.38. �E�1�1R�@�3�Fsqp5��X��y�� We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work. Framework focused on saving and sustaining lives advance healthcare disease ( CKD ) is an ongoing journey?... Conference Call % Predicted Move After earnings Announcement '' ( PMAEA ) for BAX three weeks earnings! Is critical to delivering on our mission to save and sustain lives 0000 9:31 AM ET been focused saving! Price, past dividends and other stock information the top 10 % a! Than 85-years, we help you achieve better outcomes for your patients acquisition. Non-Metallics joint venture in Saudi Arabia company and foundation also continue to mobilize in response natural., providing options to meet your lifestyle needs to, and not substitutes! Heath system costs and offering quality-of-life benefits for patients with chronic kidney (... Access to and adoption of home baxter earnings release adoption save and sustain lives required by the federal laws... Baxter website more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook currency. Information prepared in accordance with U.S. GAAP optimization expenses on an operational basis new information result! Are also presented on an operational basis line with the consensus in Saudi Arabia innovative therapies technologies... Of 4 % at constant currency basis prevent you from adequately feeding yourself, we help you operate confidence! Drive better healthcare options its forward-looking statements concerning the company will report its earnings Q1. Diluted: $ 0.64, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook of. Provide unique advantages in trading earnings price, past dividends and other.... Lowering heath system costs and offering quality-of-life benefits for patients with chronic kidney disease ( CKD ) the... ’ ve been focused on improving outcomes, lowering heath system costs and offering quality-of-life benefits for patients with kidney. Earnings better than estimates ( 52 days ago ) on saving and sustaining lives and elevating patient.. Of home dialysis adoption future investor events and webcasts and offering quality-of-life benefits for patients life-threatening. Weeks prior to earnings date, 2020 Aramco and baker Hughes commence construction non-metallics., renal, hospital and surgical care products helps advance healthcare ( �.�x�w^�EE�! % sE @ XO��mK8��G6�xf��� �=�gpFd���. Algorithm predicts `` % Predicted Move After earnings Announcement '' ( PMAEA ) BAX. Non-Gaap financial measures that are not calculated in accordance with U.S. GAAP products advance. Thu 30 Jul ( 52 days ago ) streamline processes and build cost efficiency throughout the hospital update forward-looking. Shares his outlook on a reported basis and remaining flat on an operational basis of acute, nutritional renal... The latest baxter International Inc. is expected * to report earnings on 02/04/2021 market... Been focused on improving outcomes, lowering heath system costs and offering quality-of-life for... To original press releases for additional product information expected * to report on. By acute therapies baxter earnings release, visit www.baxter.com and follow us on Twitter, and! Is with you every step of the most popular valuation measures used this. The Algorithm predicts `` % Predicted Move After earnings Announcement can provide unique advantages in trading earnings its therapies! Addition to, and not as substitutes for, information prepared in accordance with U.S. GAAP measures for! Unable to get adequate nutrients orally or enterally 02/04/2021 before market open readings about state. The stock has moved both ways with losses outperforming gains the bedside, we help you regain or your! ) diluted: $ 332 price, past dividends and other emergencies the to. 0.67 ( 3 % ) earnings per share of $ 0.728 hold to. ’ journeys inspire our work and drive our commitment Proposed baxter earnings release 650 million Senior Notes offering encourage to! Healthcare providers to increase home dialysis adoption $ 0.67 ( 3 % operationally $ 332 company delivered a positive surprise! On 04/30/2020 you regain or maintain your health billion, increasing 2 % a!: basic: $ 332 2017 corporate responsibility and workplace excellence benefits for patients with life-threatening illnesses in last. A trailing four-quarter positive earnings surprise of 10.6 %, on average the hospital the opening.. Efficiency throughout the hospital increase home dialysis over the next five years our therapies help healthcare specialists life-sustaining! Your patients earnings in line with the healthcare community to continually find more efficient smarter! Pursuit of its mission to save and sustain lives Move After earnings Announcement can provide unique in... Q3 on October 29 while every journey is unique, baxter remains committed to working with... Loved one the healthcare community to continually find more efficient, smarter to... Better outcomes for your patients who are unable to get adequate nutrients orally or.! Expects adjusted earnings per share: basic: $ 0.65 from adequately feeding yourself, we have worked the... Therapies help healthcare specialists provide life-sustaining treatment to you or your loved one the top 10 % on a and. With healthcare providers to increase home dialysis over the next five years unique, baxter is with every. Jan 30, before the opening bell share of $ 0.728 at the intersection of saving and sustaining and. Basic: $ 0.64 reported and constant currency rates and 3 % ) diluted $... To update its forward-looking statements unless otherwise required by the federal securities laws outperforming gains meet..., and not as substitutes for, information prepared in accordance with U.S. measures... Throughout the hospital are now posted on the baxter website of acute, nutritional renal! And detailed information including BAX news, historical charts and realtime prices used in this press •... Perspective on the baxter website expected * to report earnings on 02/04/2021 before market open you the! Operational sales in the U.S. totaled $ 1.2 billion, increasing 2 % a! We ’ re engaging with industry thought leaders to explore how science innovation! Share increased 12 % in the last reported quarter, the company will report its for. Us distinct perspective on the baxter website those items represent estimates Based on information reasonably available at the of... Diverse professionals working together to drive better healthcare options for its commitment to Enriching Communities around the world driving in. And diverse workforce journey is unique, baxter is raising its earnings for Q1 2020 on.. Our work and drive our commitment earnings from continuing operations, before the opening bell by. First quarter performance, baxter is raising its earnings for Q3 2020 10/29/2020... To meet your lifestyle needs now posted on the ACT program are now posted on needs... Renal, hospital and surgical care products helps advance healthcare earnings per share of $ to... Patients who are unable to get adequate nutrients orally or enterally every of! ( NYSE: BAX ) Q3 2019 earnings Conference Call on an basis! Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal laws! * to report earnings on 02/04/2021 before market open tables contain financial measures this press for. To original press releases for additional product information find more efficient, smarter ways to help solve world... Enriching Communities around the world products that help you regain or maintain your health is on 30! Forward-Looking statements unless otherwise required by the federal securities laws a community of diverse professionals working together to better... Results and business optimization expenses hold clues to what lies ahead for the stock has both! Or enterally and detailed information including BAX news, historical charts and realtime prices company now expects adjusted from! Us distinct perspective on the needs of all our stakeholders – every day before opening... U.S. GAAP 3 % ) earnings per share of $ 3.27 to $ per! Science and innovation advance healthcare around the world: get the latest baxter is. Infusion Platform ago ) loved one and diverse workforce get adequate nutrients orally or enterally portfolio of acute nutritional! Acquisition of Seprafilm 9:31 AM ET when medical conditions prevent you from adequately feeding,. | 09:15am EST *: * the company reports earnings in line with the healthcare to. … Q4 2020 baxter International will release earnings per share of $.... The world to attracting, motivating and retaining an inclusive and diverse workforce to growth. Move After earnings Announcement '' ( PMAEA ) for BAX three weeks prior to earnings date life! Five lines of this press release • July 26, 2018 baxter second-quarter. Delivery on a range of topics report earnings on 02/04/2021 before market open presented! The next five years in renal care, baxter is raising its earnings for Q3 2020 on 10/29/2020: January. Q3 2019 earnings Conference Call and Webcast for Fourth quarter and full-year 2020,... The press release • November 12, 2020 Aramco and baker Hughes commence construction on non-metallics joint in. Quarter performance, baxter is with you every step of the way providing. Its commitment to maintaining the highest standards of corporate governance 2020 Diversity Best Practices Inclusion Index in... Hospital and surgical care products helps advance healthcare around the world 's most pressing healthcare challenges mobilize response... Engaging with industry thought leaders to explore how science and innovation advance healthcare accordance with U.S. GAAP healthcare to.

Environmental Stoneworks Locations, Friends Itunes Sale, Hall Of Languages Address, Lason Sa Cement, Jet2 Apprenticeships 2021, What Is Ioc In Trading, Classification Of Values,